Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Rhodopsin (RHO) promoter is a critical regulatory DNA sequence located upstream of the RHO gene, primarily responsible for directing the high-level, rod-specific expression of the rhodopsin protein in the retina (NIH, 2023). Rhodopsin is a specialized G protein-coupled receptor (GPCR) that initiates the phototransduction cascade, allowing for vision in dim light conditions (UniProt, 2024). Mutations within the RHO gene or its regulatory elements are a primary cause of Retinitis Pigmentosa (RP), particularly the autosomal dominant form (adRP), which leads to progressive rod cell death and eventual blindness (PubMed, 2021). In the field of precision medicine, the RHO promoter is targeted by experimental gene-editing tools like CRISPR-Cas9 and CRISPR interference (CRISPRi) to selectively silence mutant alleles or modulate gene dosage (Nature Communications, 2016). Furthermore, the promoter is frequently incorporated into viral vectors, such as Adeno-associated virus (AAV), to ensure that therapeutic transgenes are expressed exclusively within rod photoreceptors, minimizing off-target effects in other retinal layers (Molecular Therapy, 2020). Precise regulation of this promoter is vital, as both the absence of rhodopsin and its excessive accumulation can lead to photoreceptor degeneration and permanent vision loss (PubMed, 2018).
Targeted transcriptional modulation and gene editing to regulate the expression levels of the rhodopsin gene in rod photoreceptors.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rhodopsin promoter (RHO promoter) (RHO promoter).